Resumen

GUERRERO, María Cielo Duran  y  PALACIOS, Juan Carlos Pozo. Treatments used for Dravet syndrome. Vive Rev. Salud [online]. 2023, vol.6, n.16, pp.172-182.  Epub 14-Feb-2023. ISSN 2664-3243.  https://doi.org/10.33996/revistavive.v6i16.216.

Dravet syndrome (DS) is estimated to be a severe developmental and epileptic encephalopathy, occurring in 1 in 15000 live births. It is characterized by drug-resistant epilepsy presenting in the first year of life with prolonged seizures accompanied by fever or temperature changes, often hemiclonic in nature, followed by unprovoked seizures of various types. Objective. To describe the treatments used for Dravet syndrome. Methodology. A systematic review was performed. For this purpose, a search was carried out in multiple databases, such as Pubmed, Dialnet, Sciencedirect, Scielo and Scopus. The search was limited to articles published from 2017 to 2022. After collecting the articles, several filtering criteria were applied to ensure that only those studies that were relevant to the analysis were included. Conclusion. Current treatments, such as antiepileptic drugs, ketogenic diets, and nerve stimulation, have been shown to be effective in reducing the frequency and severity of seizures in patients. It is important that patients and their caregivers work together with a medical team to achieve the best possible management of the disease. Although there is no definitive cure for Dravet syndrome, medical advances continue to provide hope and treatment options for patients and their families.

Palabras clave : Therapeutics; Diagnosis; Epilepsy.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )